Monday, 25 Mar 2019

You are here

Using Synovial Tissue Biopsies to Develop Precision Medicine for Rheumatoid Arthritis

Researchers at Northwestern University have used ultrasound-guided tissue biopsy from the joints to analyze the genes of tissue macrophages with the hope that transcriptional profiling of synovial macrophages may be correlated with clinical parameters or drug responsiveness in rheumatoid arthritis (RA) patients.(Citation source: https://buff.ly/2FPmgKA)

This attempt at precision medicine is driven by the "trial and error" approach to RA therapy, low response or incomplete response to very good drugs and evidence showing no correlations with blood sampling or clinical parameters.

This was a multi-site study of 41 rheumatoid arthritis patients who underwent US-guided synovial biopsies.

Participating sites included Northwestern University; the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.

Whole tissue samples from RA patients had a high degree of transcriptional heterogeneity. However,  the transcriptional profile of isolated RA synovial macrophages highlighted a subpopulation of patients and identified six novel transcriptional modules that were associated with disease activity and therapy. 

In the next phase of research, investigators will do pre- and post treatment (6 weeks later) biopsies to identify predictor gene sequence that will clearly identify which patients respond to a particular therapy.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Artificial Intelligence to Predict Rheumatoid Disease Activity

A recent study in JAMA Network Open shows that artificial intelligence models can use electronic health record data to prognosticate future patient outcomes in rheumatoid arthritis (RA).

Multiple Delays in Referral of New RA Patients

A UK study of early onset arthritis or new rheumatoid arthritis patients shows multiple sources of delayed referral to the first rheumatology consultation.

Does Smoking Cessation Reduce RA Risk?

Individuals who quit smoking and maintained their nonsmoking status over a long duration of time had a decreased risk of developing seropositive rheumatoid arthritis (RA), an analysis of two large prospective cohorts found. 

Remission Unlikely in RA

Dr. Marwan Bukhari (editor of Rheumatology) has written an editorial wherein he suggests that true remission is hard to achieve. He notes that "remission as a target is a noble objective that we should all aspire to but we should not chastise our practice if we do not achieve it, as more and more evidence suggests that we should consider it the ideal but not the norm."

No Added Benefit to MRI-Guided Therapy in Rheumatoid Arthritis

A treat-to-target (T2T) strategy to manage rheumatoid arthritis hinges on clinical metrics to optimize therapy. But investigators from Denmark have shown that using magnetic resonance imaging–guided T2T failed to improve disease activity remission rates or reduce radiographic progression.